Biosimilars Create Opportunities for Sustainable Cancer Care

Lugano, Switzerland – Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open. The document outlines approval standards for biosimilars, how to safely introduce them into the clinic, and the potential benefits for patients and healthcare systems.
Comments
Leave a Comment